Información financiera

Debates Datos técnicos Estacionales

EBITDA de Psyence Biomedical Ltd..

Datos anuales

2022

2023

TTM

‪‪−2,80 M‬‬

‪‪−2,10 M‬‬

‪‪−1,40 M‬‬

‪‪−700,00 K‬‬

‪0,00‬

Periodo

Valor

Cambio

% cambio

TTM

—

—

—

2023

‪‪−2,75 M‬‬

‪‪−1,46 M‬‬

‪−112,64‬%

2022

‪‪−1,29 M‬‬

‪‪−959,69 K‬‬

‪−287,08‬%

Datos trimestrales

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q2 '24

‪‪−1,20 M‬‬

‪‪−900,00 K‬‬

‪‪−600,00 K‬‬

‪‪−300,00 K‬‬

‪0,00‬

Periodo

Valor

Cambio

% cambio

Q2 '24

‪‪−1,16 M‬‬

‪‪−599,05 K‬‬

‪−107,54‬%

Q3 '23

‪‪−557,05 K‬‬

‪‪−44,96 K‬‬

‪−8,78‬%

Q2 '23

‪‪−512,09 K‬‬

+‪‪259,40 K‬‬

+‪33,62‬%

Q1 '23

‪‪−771,49 K‬‬

‪‪−260,56 K‬‬

‪−51,00‬%

Q4 '22

‪‪−510,93 K‬‬

‪‪−347,80 K‬‬

‪−213,20‬%

Q3 '22

‪‪−163,13 K‬‬

+‪‪129,89 K‬‬

+‪44,33‬%

Q2 '22

‪‪−293,02 K‬‬

+‪‪33,88 K‬‬

+‪10,36‬%

Q1 '22

‪‪−326,90 K‬‬

‪‪−72,10 K‬‬

‪−28,30‬%

Q4 '21

Q3 '21

Q2 '21